Hepatocyte mARC1 promotes fatty liver disease
Lewis LC. et al, (2023), JHEP Reports, 5
MLX plays a key role in lipid and glucose metabolism in humans: evidence from in vitro and in vivo studies
NAGARAJAN S. et al, (2023), Metabolism: clinical and experimental
Nutritional regulation of hepatic de novo lipogenesis in humans.
Cross E. et al, (2023), Curr Opin Clin Nutr Metab Care, 26, 65 - 71
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.
Othonos N. et al, (2023), Nat Commun, 14
An optimised protocol for the investigation of insulin signalling in a human cell culture model of adipogenesis.
Gamwell JM. et al, (2023), Adipocyte
Detection and alterations of acetylcarnitine (AC) in human liver by 1 H MRS at 3T after supplementation with l-carnitine.
Savic D. et al, (2022), Magn Reson Med
Determining the temporal, dose, and composition effects of nutritional substrates in an in vitro model of intrahepatocellular triglyceride accumulation.
Nagarajan SR. et al, (2022), Physiol Rep, 10
The PNPLA3 I148M variant increases intrahepatic lipolysis and beta oxidation and decreases de novo lipogenesis and hepatic mitochondrial function in vivo in humans
Luukkonen PK. et al, (2022), DIABETOLOGIA, 65, S76 - S76
Intrahepatic triglyceride content: influence of metabolic and genetics drivers.
Dearlove DJ. and Hodson L., (2022), Curr Opin Clin Nutr Metab Care, 25, 241 - 247
The PNPLA3 I148M variant increases intrahepatic lipolysis and beta oxidation and decreases de novo lipogenesis and hepatic mitochondrial function in humans
Luukkonen P. et al, (2022), JOURNAL OF HEPATOLOGY, 77, S690 - S691
Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents.
Hazlehurst JM. et al, (2022), Metabol Open, 14
The effects of endogenously- and exogenously-induced hyperketonemia on exercise performance and adaptation.
Dearlove DJ. et al, (2022), Physiol Rep, 10
Obesity due to Steroid Receptor Coactivator-1 deficiency is associated with endocrine and metabolic abnormalities.
Cacciottolo TM. et al, (2022), J Clin Endocrinol Metab
Soat2 ties cholesterol metabolism to β-oxidation and glucose tolerance in male mice.
Pramfalk C. et al, (2022), J Intern Med
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.
Green CJ. et al, (2022), Eur J Endocrinol
Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism
Nagarajan SR. et al, (2021), Proceedings of the Nutrition Society, 1 - 23
Bariatric surgery restores dysregulated hepatic lipid metabolism and promotes regression across the spectrum of NAFLD
Dempster N. et al, (2021), OBESITY SURGERY, 31, S16 - S16
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease.
Luukkonen PK. et al, (2021), J Hepatol
Overfeeding Saturated Fat Increases LDL (Low-Density Lipoprotein) Aggregation Susceptibility While Overfeeding Unsaturated Fat Decreases Proteoglycan-Binding of Lipoproteins.
Ruuth M. et al, (2021), Arterioscler Thromb Vasc Biol